Day 3 parasitemia and mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda.

Artemisinin resistance threatens malaria control and elimination efforts globally. Recent studies have reported the emergence of parasites tolerant to artemisinin agents in sub-Saharan Africa, including Uganda. The current study assessed the day 3 parasite clearance and its correlation with propeller gene () mutations in parasites isolated from patients with uncomplicated malaria under artemether-lumefantrine (AL) treatment.